By Yasin Ebrahim
Investing.com – Intuitive Surgical (NASDAQ:) reported on Thursday third-quarter results that beat analysts’ forecasts top both the top and bottom lines, though warned a resurgence of Covid-19 in some states would continue to hurt sales.
Intuitive Surgical shares lost 3.52% in after-hours trade following the report.
“The impact and timing of the COVID-19 pandemic on the company’s business differs by geography. In the U.S., for example, while da Vinci procedures have recovered a significant portion of the pre-COVID-19 levels, the resurgence of COVID-19 in some states has had, and will likely continue to have, an adverse impact on the company’s procedure volumes,” Intuitive Surgical said.
Intuitive Surgical announced per share of $2.77 on revenue of $1.08B. Analysts polled by Investing.com anticipated EPS of $2.02 on revenue of $967.56M.
The fall in revenue was driven by fewer system placements, primarily as a result of the significant impact of the Covid-19 pandemic, as well as a $23 million decrease in service revenue related to service fee credits from its customer relief program, the company said.
The company shipped 195 da vinci surgical systems, a decrease of 29% compared with 275 in the third quarter of 2019.
Intuitive Surgical shares are up 25% from the beginning of the year, still down 4.47% from its 52 week high of $777.00 set on September 2. They are under-performing the which is up 36.25% from the start of the year.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.